Literature DB >> 8336193

Contralateral breast cancer: clinical characteristics and impact on prognosis.

E A Healey1, E F Cook, E J Orav, S J Schnitt, J L Connolly, J R Harris.   

Abstract

PURPOSE: To determine the characteristics of patients with unilateral breast cancer who subsequently develop contralateral breast cancer (CBC), to assess their prognosis relative to patients who do not develop a CBC, and to assess the feasibility of using conservative surgery (CS) and radiotherapy (RT) to treat CBC.
MATERIALS AND METHODS: Of 1,624 women treated with CS and RT for unilateral stage I or II breast cancer at the Joint Center for Radiation Therapy, 77 developed an invasive CBC. Sixty-two CBCs were treated with CS and RT. The median follow-up duration was 95 months from the time of initial breast cancer diagnosis, and 63 months from CBC diagnosis.
RESULTS: The cumulative actuarial rate of CBC was 7.0% at 10 years, and the annual incidence rate for CBC was relatively constant. Young age predicted for CBC. When age was analyzed by decade the relative risk (RR) for older patients compared with younger patients was 0.79 (95% confidence interval [CI], 0.62 to 1.01). The presence of lobular carcinoma in situ (LCIS), higher tumor stage, and lack of adjuvant systemic therapy also predicted for CBC with borderline significance. Multivariate analyses showed that CBC was associated with a statistically significant greater likelihood of local recurrence (LR) or distant recurrence (RR, 1.68; 95% CI, 1.03 to 2.71), and distant-only recurrence (RR, 2.17; 95% CI, 1.28 to 3.69). Among assessable patients treated with bilateral RT, 28 of 31 ipsilateral and 11 of 11 contralateral breasts had an excellent or good overall cosmetic outcome at 5 years, and treatment-related complications were minimal.
CONCLUSION: We conclude that (1) young age is associated with a greater likelihood of CBC, (2) patients who develop a CBC have a greater subsequent risk of distant relapse as compared with patients without CBC, and (3) it is feasible to deliver sequential nonoverlapping bilateral RT without compromising the cosmetic outcome or increasing complications.

Entities:  

Mesh:

Year:  1993        PMID: 8336193     DOI: 10.1200/JCO.1993.11.8.1545

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  28 in total

1.  Concurrent breast stroma sarcoma and breast carcinoma: a case report.

Authors:  Ramon Andrade de Mello; Paulo Figueiredo; Mariela Marques; Gabriela Sousa; Teresa Carvalho; Helena Gervásio
Journal:  J Med Case Rep       Date:  2010-12-23

2.  Discussions about contralateral prophylactic mastectomy among surgical oncology providers and women with sporadic breast cancer: a content analysis.

Authors:  Thomas A D'Agostino; Abenaa M Brewster; Susan K Peterson; Isabelle Bedrosian; Patricia A Parker
Journal:  Transl Behav Med       Date:  2020-05-20       Impact factor: 3.046

Review 3.  Current knowledge on contralateral prophylactic mastectomy among women with sporadic breast cancer.

Authors:  Abenaa M Brewster; Patricia A Parker
Journal:  Oncologist       Date:  2011-06-14

4.  Prospective Study of Surgical Decision-making Processes for Contralateral Prophylactic Mastectomy in Women With Breast Cancer.

Authors:  Patricia A Parker; Susan K Peterson; Isabelle Bedrosian; Melissa A Crosby; Yu Shen; Dalliah M Black; Gildy Babiera; Henry M Kuerer; Jun Ying; Wenli Dong; Scott B Cantor; Abenaa M Brewster
Journal:  Ann Surg       Date:  2016-01       Impact factor: 12.969

5.  Low Lifetime Risk of Contralateral Breast Cancer in a Middle-Income Asian Country: Evidence to Guide Post-treatment Surveillance.

Authors:  M H See; N Bhoo-Pathy; S Jamaris; A Kiran; D G Evans; C H Yip; N A Taib
Journal:  World J Surg       Date:  2018-05       Impact factor: 3.352

6.  Synchronous and metachronous bilateral breast cancer: a long-term single-institution experience.

Authors:  Robert Díaz; Blanca Munárriz; Ana Santaballa; Laura Palomar; Joaquín Montalar
Journal:  Med Oncol       Date:  2010-12-31       Impact factor: 3.064

7.  Prognostic significance of synchronous and metachronous bilateral breast cancer.

Authors:  J Kollias; I O Ellis; C W Elston; R W Blamey
Journal:  World J Surg       Date:  2001-09       Impact factor: 3.352

Review 8.  The impact of age on outcome in early-stage breast cancer.

Authors:  Beth M Beadle; Wendy A Woodward; Thomas A Buchholz
Journal:  Semin Radiat Oncol       Date:  2011-01       Impact factor: 5.934

9.  Contralateral prophylactic mastectomy in the American College of Radiology Imaging Network 6667 trial: effect of breast MR imaging assessments and patient characteristics.

Authors:  Habib Rahbar; Lucy G Hanna; Constantine Gatsonis; Mary C Mahoney; Mitchell D Schnall; Wendy B DeMartini; Constance D Lehman
Journal:  Radiology       Date:  2014-06-16       Impact factor: 11.105

10.  Late tamoxifen in patients previously operated for breast cancer without postoperative tamoxifen: 5-year results of a single institution randomised study.

Authors:  Andrea Veronesi; Gianmaria Miolo; Maria D Magri; Diana Crivellari; Simona Scalone; Ettore Bidoli; Davide Lombardi
Journal:  BMC Cancer       Date:  2010-05-14       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.